Michael Snyder, MD
Orthopaedic Surgery · Jefferson City, MONPI 1285611095
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $331 and has fallen 59.6% since, to $134 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in MO, where the typical reported total is $4,809.
Across 75 payments — averaging $20.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$215
- Heron Therapeutics, Inc.$184
- Elite Orthopedics, LLC$145
- Pacira Therapeutics, Inc.$134
- Lundbeck LLC$115
- Ferring Pharmaceuticals Inc.$101
- plus $664 from 16 others
Across 7 payments — averaging $96,357 each. An ownership or investment interest held by the physician or an immediate family member.
- Spinal Simplicity, LLC$675K
What the payments were for
- Food & beverage$1,557100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APONVIE$163
How this compares
$1,557 in reported general payments places this provider in the 30th percentile of 455 orthopaedic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 646 | $1,936 |
| Diclofenac Sodium | 189 | $1,864 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 121 | $1,632 |
| Tramadol Hcl | 165 | $836 |
| Celecoxib | 15 | $342 |
| Methylprednisolone | 15 | $125 |
| Carisoprodol | 28 | $100 |
| Naproxen | 11 | $87 |
| Oxycodone Hcl | 12 | $82 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Jefferson City
- Jeff LehmenJefferson City$51K
- Matthew SmithColumbia$2.9M
- Jay KeenerSaint Louis$2.2M
- John WatsonSaint Louis$1.7M
- Peter ChalmersSaint Louis$603K
- Katherine BurnsBridgeton$491K
- Jeremy StattonLees Summit$457K
- Lionel MetzSaint Louis$428K
- Michael HellmanLees Summit$365K
- Jon CarlsonSaint Louis$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.